Articles

Find an Article

Filter articles

Applied Filters

Showing 1 to 10 of 51 results

Predicting the unpredictable during pregnancy

International19-04-2022Fran Salisbury and Alice Jefferies

A pressing need for more non-invasive prenatal tests is leading to increasing IP activity and commercial interest, say Fran Salisbury and Alice Jefferies of Mewburn Ellis.

When alliances fail, is arbitration the answer?

24-02-2022

The global pandemic has increased collaboration and a new wave of disputes is likely. Arbitration is well placed to help, argue Kate Davies McGill, Gaela Gehring Flores and Paul Keller of Allen & Overy

UK experimental use exemptions: Part 4—the SPC manufacturing and stockpiling waiver

EU10-08-2021Sophie Topham

In the final article of a four-part series, Sophie Topham of Marks & Clerk discusses the supplementary protection certificate manufacturing waiver.

UK experimental use exemptions: Part 3—the expanded exemption

UK05-08-2021Sophie Topham

In the third article of a four-part series on experimental use exemptions from infringement in the UK, Sophie Topham of Marks & Clerk considers the expansion of the original exemption.

Second medical use: a regulatory perspective

UK08-02-2021Jackie Mulryne

Under close scrutiny by regulators, the rules around second medical use patents vary from country to country, explains Jackie Mulryne of Arnold & Porter.

What 2020 means for the life sciences

International, UK15-12-2020Sally Shorthose and Rumana Khanom

Between Brexit and COVID-19, 2020 has had seismic implications for the life sciences industries. Sally Shorthose and Rumana Khanom of Bird & Bird report.

SPCs: a deep dive into CJEU case law

23-06-2020Katie Cambrook and Ben Millson

The CJEU’s many attempts to clarify the law around SPCs has created more questions than answers, as Katie Cambrook and Ben Millson of Bristows explain.

Lanham Act: brand owners’ current weapon of choice

11-06-2020

As opportunistic price-gougers look to capitalise on the COVID-19 pandemic, brands such as 3M have turned to trademark law to try and stop them. Brian Michalek and Erin Westbrook of Saul Ewing Arnstein & Lehr report.

COVID-19: governments look to shield companies from IP enforcement

UK23-04-2020Andrew Pitts

The UK government’s indemnifying of ventilator manufacturers is a smart solution to potential licensing obstacles, says Andrew Pitts of Mewburn Ellis.

Patent pools: should rights owners give up their IP?

21-04-2020Rory O'Neill

Pressure is building on IP owners to offer up access to technology that could help fight COVID-19. Rory O'Neill looks at some of the implications for the patent system.

Showing 1 to 10 of 51 results

LSIPR